# Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

> **NCT03920059** · PHASE4 · TERMINATED · sponsor: **Chulalongkorn University** · enrollment: 2 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT03920059
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-20
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow recruitment rate
- **Last updated:** 2021-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03920059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03920059, "Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03920059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*